MICHAEL SEITZ: Open Payments
NPI 1760037287 · BROOKSVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,566 in 79 payments from 22 companies in 2025. Trend: 2023 $1,323 · 2024 $1,649 · 2025 $1,566
Food & beverage: $1,566
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $291 |
| AstraZeneca Pharmaceuticals LP | 9 | $207 |
| Amgen Inc. | 11 | $179 |
| ABBVIE INC. | 6 | $158 |
| PFIZER INC. | 11 | $138 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $94 |
| GlaxoSmithKline, LLC. | 5 | $88 |
| Exact Sciences Corporation | 4 | $69 |
| Dexcom, Inc. | 1 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
Products named: OTEZLA, Ozempic, Wegovy, CAPLYTA, NURTEC ODT, BREZTRI, VRAYLAR, UBRELVY.
Industry payments across FL — which companies pay providers there.
